BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18752389)

  • 21. Ezetimibe + simvastatin (Merck/Schering-Plough).
    Flores NA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased epistaxis with use of ezetimibe/simvastatin.
    Shah B; McAllister A; Davidson TM
    Ann Pharmacother; 2009 Sep; 43(9):1545. PubMed ID: 19671801
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure.
    Schneider R; Bercker S; Schubert S; Tillmann HL; Fangmann J; Hauss J; Bartels M
    Transplant Proc; 2009 Nov; 41(9):3934-6. PubMed ID: 19917416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
    Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
    Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin-induced lactic acidosis: a rare adverse reaction?
    Goli AK; Goli SA; Byrd RP; Roy TM
    Clin Pharmacol Ther; 2002 Oct; 72(4):461-4. PubMed ID: 12386648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin induced rhabdomyolysis and an important clinical link with hypothyroidism.
    Kiernan TJ; Rochford M; McDermott JH
    Int J Cardiol; 2007 Jul; 119(3):374-6. PubMed ID: 17098308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
    Kashani A; Sallam T; Bheemreddy S; Mann DL; Wang Y; Foody JM
    Am J Cardiol; 2008 Jun; 101(11):1606-13. PubMed ID: 18489938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe.
    van Heyningen C
    Ann Clin Biochem; 2005 Sep; 42(Pt 5):402-4. PubMed ID: 16168199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of thyroid follicular adenoma on simvastatin therapy.
    McCord EL; Goenka S
    Tenn Med; 2000 Jun; 93(6):210-2. PubMed ID: 10846948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report of simultaneous acute pancreatitis and acute hepatitis in a patient taking ezetimibe/simvastatin.
    Van Woerkom RC; Adler DG
    J Clin Lipidol; 2010; 4(4):314-5. PubMed ID: 21122666
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients.
    Quarta CC; Potena L; Grigioni F; Scalone A; Magnani G; Coccolo F; Fallani F; Russo A; Branzi A
    J Heart Lung Transplant; 2008 Jun; 27(6):685-8. PubMed ID: 18503971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
    van der Graaf A; Cuffie-Jackson C; Vissers MN; Trip MD; Gagné C; Shi G; Veltri E; Avis HJ; Kastelein JJ
    J Am Coll Cardiol; 2008 Oct; 52(17):1421-9. PubMed ID: 18940534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 34. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.
    Molden E; Andersson KS
    Pharmacotherapy; 2007 Apr; 27(4):603-7. PubMed ID: 17381388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
    Rodríguez-Ferrero ML; Anaya F
    Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.
    Schmidt GA; Hoehns JD; Purcell JL; Friedman RL; Elhawi Y
    J Am Board Fam Med; 2007; 20(4):411-6. PubMed ID: 17615423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ezetimibe--an update.
    Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: fulminant hepatic failure involving duloxetine hydrochloride.
    Hanje AJ; Pell LJ; Votolato NA; Frankel WL; Kirkpatrick RB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):912-7. PubMed ID: 16797245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bicalutamide-associated fulminant hepatotoxicity.
    O'Bryant CL; Flaig TW; Utz KJ
    Pharmacotherapy; 2008 Aug; 28(8):1071-5. PubMed ID: 18657023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.
    Martin JE; Cavanaugh TM; Trumbull L; Bass M; Weber F; Aranda-Michel J; Hanaway M; Rudich S
    Clin Transplant; 2008; 22(1):113-9. PubMed ID: 18217912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.